Connect with us
Colombia’s therapeutic cannabis industry grew 25–35% last year, driven by regulatory stability, medical acceptance, and rising prescriptions. Nearly 25% of Colombians have used medicinal or cosmetic...
Spain’s medicines agency AEMPS has launched the registration process for standardized medicinal cannabis preparations. Pharmaceutical laboratories must apply electronically under the October 7 royal decree, which...
In 2025, Colombia’s medical cannabis industry grew 25%–35%, driven by regulatory stability, expanding exports, and increased medical adoption. Pharmaceutical products led demand, oils dominated sales, and...
Poland’s Ministry of Justice held a rare, lengthy meeting with Free Hemp activists to discuss decriminalizing cannabis, including a proposed 10-gram possession threshold via prosecutorial guidelines....
A December 2025 US executive order signals a major policy shift by treating medical cannabis as a public health issue rather than a tolerated exception. It...
Agential Cannabis 2026, Asia-Pacific’s premier medical cannabis trade fair and conference, will be held on September 23–24 at Bangkok’s BITEC. Bringing together industry leaders, regulators, and...
In 2025 Poland, legal medical cannabis has clear quality, safety, and dosing advantages over unpredictable illegal street product, making therapeutic use more sensible than recreational smoking....
In 2025, medical cannabis use in Poland stabilized and matured. Pharmacies dispensed over 5 tons to 105,000 patients through 537,000 prescriptions. Growth slowed after rapid expansion...
Europe’s cannabis reputation often points to the Netherlands or Portugal, yet Malta and Luxembourg made the real breakthrough by granting a legal right to home cultivation....
On December 15, 2025, President Trump confirmed his administration is strongly considering reclassifyingcannabis from Schedule I to Schedule III. While not full legalization, the shift would...